
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
POTENTIAL OF NANOPARTICLES FOR THE DELIVERY OF ANTIDEPRESSANTS
*Sahil Gorwade and Dr. B. Wilson
. Abstract History: The development of the 20th century was the creation of categories to classify various mental illnesses. If you were having trouble with depression, you should go lay on the stereotypical psychologist’s couch and engage in talk therapy. The Freudians were more interested in treating the psychological causes of mental illness, while the psychobiological camp argued that they could treat the symptoms with drugs. Also debated were the new categories of mental illness that were created to assist clinicians in making clear diagnoses purposes. Drug companies pushed for the new categories of drug under FDA regulations. The rate of depression in the U.S. has increased dramatically over the last century. In 1905, just 1% of Americans reported a major depressive episode by age 75. In 1955, 6% experienced a major depressive episode by age 24.[1] Keywords: . [Full Text Article] [Download Certificate] |
